Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yate-Ching Yuan

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|July 6, 2007
New experimental models for aromatase inhibitor resistanceShiuan Chen, Selma Masri, Yanyan Hong, et al.
Cancer Research|January 20, 2004
In vitro characterization of enzymatic properties and inhibition of the p53R2 subunit of human ribonucleotide reductaseJimin Shao, Bingsen Zhou, Lijun Zhu, et al.
Molecular Cancer Research : MCR|April 16, 2005
Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approachToru Itoh, Kim Karlsberg, Ikuko Kijima, et al.
Journal of Molecular Graphics & Modelling|September 29, 2009
Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3Jianping Lin, Ralf Buettner, Yate-Ching Yuan, et al.
Cancer Research|June 19, 2008
Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptorSelma Masri, Sheryl Phung, Xin Wang, et al.
Biochemistry|September 5, 2009
2.6 A X-ray crystal structure of human p53R2, a p53-inducible ribonucleotide reductase Peter Smith, Bingsen Zhou, Nam Ho, et al.
Molecular Therapy. Oncology|March 26, 2026
CBX6 and CA9 as predictive indicators and therapeutic targets in GBMYujun Wang, Yongsheng Jia, Yate-Ching Yuan, et al.
Journal of the American College of Surgeons|January 19, 2021
Tumor Epigenetic Signature and Survival in Resected Gastric Cancer PatientsYanghee Woo, Carolyn E Behrendt, Annie Yang, et al.
Plos One|December 4, 2009
Epitope characterization of an aromatase monoclonal antibody suitable for the assessment of intratumoral aromatase activityYanyan Hong, Hongzhi Li, Jingjing Ye, et al.
Molecular Cancer Therapeutics|December 24, 2005
A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductasesBingsen Zhou, Jimin Shao, Leila Su, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
The Journal of Steroid Biochemistry and Molecular Biology|July 6, 2007
New experimental models for aromatase inhibitor resistanceShiuan Chen, Selma Masri, Yanyan Hong, et al.
Cancer Research|January 20, 2004
In vitro characterization of enzymatic properties and inhibition of the p53R2 subunit of human ribonucleotide reductaseJimin Shao, Bingsen Zhou, Lijun Zhu, et al.
Molecular Cancer Research : MCR|April 16, 2005
Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approachToru Itoh, Kim Karlsberg, Ikuko Kijima, et al.
Journal of Molecular Graphics & Modelling|September 29, 2009
Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3Jianping Lin, Ralf Buettner, Yate-Ching Yuan, et al.
Cancer Research|June 19, 2008
Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptorSelma Masri, Sheryl Phung, Xin Wang, et al.
Biochemistry|September 5, 2009
2.6 A X-ray crystal structure of human p53R2, a p53-inducible ribonucleotide reductase Peter Smith, Bingsen Zhou, Nam Ho, et al.
Molecular Therapy. Oncology|March 26, 2026
CBX6 and CA9 as predictive indicators and therapeutic targets in GBMYujun Wang, Yongsheng Jia, Yate-Ching Yuan, et al.
Journal of the American College of Surgeons|January 19, 2021
Tumor Epigenetic Signature and Survival in Resected Gastric Cancer PatientsYanghee Woo, Carolyn E Behrendt, Annie Yang, et al.
Plos One|December 4, 2009
Epitope characterization of an aromatase monoclonal antibody suitable for the assessment of intratumoral aromatase activityYanyan Hong, Hongzhi Li, Jingjing Ye, et al.
Molecular Cancer Therapeutics|December 24, 2005
A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductasesBingsen Zhou, Jimin Shao, Leila Su, et al.
Pageof 11